Sequential Treatment with Epirubicin/Cyclophosphamide, Followed by Docetaxel Is Equieffective, but Less Toxic Than FEC120 in the Adjuvant Treatment of Breast Cancer Patients with Extensive Lymph Node Involvement: The German ADEBAR Phase III Study.

Dokumenttyp:: Meeting Abstract
Autor(en):: Janni, WJ; Harbeck, N; Sommer, H; Rack, B; Augustin, D; Simon, W; Jueckstock, J; Wischnik, A; Annecke, K; Hepp, P; Friese, K; Kiechle, M
Titel:: Sequential Treatment with Epirubicin/Cyclophosphamide, Followed by Docetaxel Is Equieffective, but Less Toxic Than FEC120 in the Adjuvant Treatment of Breast Cancer Patients with Extensive Lymph Node Involvement: The German ADEBAR Phase III Study.
Zeitschriftentitel:: Cancer Res
Jahr:: 2009
Band / Volume:: 69 Suppl.
Heft / Issue:: 24
Seitenangaben Beitrag:: 522S-522S
Sprache:: eng
Print-ISSN:: 0008-5472
TUM Einrichtung:: Frauenklinik und Poliklinik
BibTeX

Vorkommen: